Using SIAH to risk stratify patients, quantify and guide immuno-oncology (IO) therapy (chemotherapy and pembrolizumab) in triple-negative breast cancer (TNBC)

Author: Jonathan Baker

Program: Graduate Student

Mentor(s): Amy Tang, PhD

Session: A

Time: 2:40 p.m.